SLC6A4 and drug-induced dyskinesia: However, a retrospective study conducted in 111 PD patients with a follow-up of at least 10 years found that administration of selective SERT inhibitors does not prevent dyskinesia development, thought it may delay their onset [138], somewhat contradicting the preclinical rodent data.